Walleye Trading’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Walleye Trading’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,500	Closed	-$145K	–	5946
2015 Q2	$145K	Sell	3,500 -300	-8%	-$10.8K	﹤0.01%	2739
2015 Q1	$135K	Sell	3,800 -1,400	-27%	-$47.4K	﹤0.01%	2481
2014 Q4	$167K	Sell	5,200 -1,500	-22%	-$43.4K	﹤0.01%	2417
2014 Q3	$189K	Buy	6,700 +6,200	+1,240%	+$189K	﹤0.01%	2124
2014 Q2	$15	Sell	500 -1,600	-76%	-$44.2K	﹤0.01%	3310
2014 Q1	$58	Sell	2,100 -7,900	-79%	-$207K	﹤0.01%	2658
2013 Q4	$256K	Buy	+10,000	New	+$308K	﹤0.01%	2006

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Walleye Trading's BRLI Position: Q3 2015 in Review

Walleye Trading sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 449 shares — an estimated $19K sold.

Walleye Trading first reported a position in BRLI in Q3 2014 and held it in 3 quarters. The position peaked at $64K in Q4 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Walleye Trading reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Walleye Trading sold 449 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $19K.
Walleye Trading first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2014 and held it in 3 quarters.
Walleye Trading's BIO-REFERENCE LABS INC-NEW- position peaked at $64K in Q4 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Walleye Trading's 13F filing for Q3 2015, filed 16 Nov 2015.